Non-coding RNAs in Rheumatoid Arthritis: From Bench to Bedside

112Citations
Citations of this article
86Readers
Mendeley users who have this article in their library.

Abstract

Rheumatoid arthritis is a common systemic and autoimmune disease characterized by symmetrical and inflammatory destruction of distal joints. Its primary pathological characters are synovitis and vasculitis. Accumulating studies have implicated the critical role of non-coding RNAs (ncRNAs) in inflammation and autoimmune regulation, primarily including microRNA (miRNA), long non-coding RNA (lncRNA), and circular RNA (circRNA). NcRNAs are significant regulators in distinct physiological and pathophysiological processes. Many validated non-coding RNAs have been identified as promising biomarkers for the diagnosis and treatment of RA. This review will shed some light on RA pathogenesis and be helpful for identifying potential ncRNA biomarkers for RA.

Cite

CITATION STYLE

APA

Wang, J., Yan, S., Yang, J., Lu, H., Xu, D., & Wang, Z. (2020, January 28). Non-coding RNAs in Rheumatoid Arthritis: From Bench to Bedside. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2019.03129

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free